Virtu Financial LLC Processa Pharmaceuticals, Inc. Transaction History

Virtu Financial LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.24 - $0.53 $3,613 - $7,979	-15,056 Reduced 56.45%	11,617 $3,000
Q2 2023 Jul 27, 2023	BUY	$0.44 - $0.73 $6,038 - $10,018	13,724 Added 105.99%	26,673 $13,000
Q1 2023 May 01, 2023	BUY	$0.41 - $1.3 $5,309 - $16,833	12,949 New	12,949 $7,000

Ticker PCSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,856,200
Market Cap $18.4M
Description
Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that is in Phase 2B clinical trials for the treatment of ulcerative and non-ulcerative necrobiosi...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.